Classic and current concepts in adrenal steroidogenesis: a reappraisal

Adrenal steroid biosynthesis and its related pathology are constant evolving disciplines. In this paper, we review classic and current concepts of adrenal steroidogenesis, plus control mechanisms of steroid pathways, distribution of unique enzymes and cofactors, and major steroid families. We highlight the presence of a mineralocorticoid (MC) pathway of zona fasciculata (ZF), where most circulating corticosterone and deoxycorticosterone (DOC) originate together with 18OHDOC, under ACTH control, a claim based on functional studies in normal subjects and in patients with 11 beta-, and 17 alpha-hydroxylase deficiencies. We emphasize key differences between CYP11B1 (118-hydroxylase) and CYP11B2 (aldosterone synthase) and the onset of a hybrid enzyme - CYP11B1/CYP11B2 -, responsible for aldosterone formation in ZF under ACTH control, in type I familial hyperaldosteronism (dexamethasone suppressible). In apparent MC excess syndrome': peripheral conversion of cortisol to cortisone is impaired by lack of 11 beta-hydroxysteroid dehydrogenase type 2, permitting free cortisol access to MC receptors resulting in severe hypertension. We discuss two novel conditions involving the synthesis of adrenal androgens: the backdoor pathway; through which dihydrotestosterone is formed directly from androsterone, being relevant for the fetoplacental setting and sexual differentiation of male fetuses, and the rediscovery of C19 11-oxygenated steroids (11-hydroxyandrostenedione and 11-ketotestosterone), active androgens and important markers of virilization in 21-hydroxylase deficiency and polycystic ovaries syndrome. Finally, we underline two enzyme cofactor deficiencies: cytochrome P450 oxidoreductase which partially affects 21- and 17 alpha-hydroxylation, producing a combined clinical/hormonal picture and causing typical skeletal malformations (Antley-Bixler syndrome), and PAPSS2, coupled to SULT2A1, that promotes sulfation of DHEA to DHEAS, preventing active androgens to accumulate. Its deficiency results in reduced DHEAS and elevated DHEA and androgens with virilization. Future and necessary studies will shed light on remaining issues and questions on adrenal steroidogenesis.

Automated summary

This paper reviews the biosynthesis and pathology of adrenal steroids, focusing on the control mechanisms and distribution of enzymes and cofactors. It highlights the presence of a mineralocorticoid pathway in the zona fasciculata and discusses the differences between CYP11B1 and CYP11B2. The paper also discusses new findings in adrenal androgen synthesis and the deficiencies of enzyme cofactors.